Similar Items: Clinical outcomes of CyberKnife stereotactic radiotherapy for localized prostate cancer: comparison of 35 Gy in 5 fractions and 36 Gy in 4 fractions
- Feasibility of nonspinal bony landmark-based image registration in CyberKnife ® robotic radiotherapy for pelvic and femoral bone tumors
- Diabetes mellitus as a potential risk factor for severe late toxicity after stereotactic body radiotherapy for prostate cancer: a large single-institution cohort study
- Safety of carbon-ion radiotherapy for prostate cancer after rectal surgery: a single-institution retrospective study
- Ensuring bladder volume reproducibility and reducing cone-beam computed tomography-related radiation exposure in prostate hypofractionated radiotherapy by a Certified Nurse in Radiation Oncology nursing
- Feasibility of retrieval-augmented generation for large language models with Japanese input in radiotherapy
- Acute skin toxicity and cosmesis outcome in non-metastatic breast cancer patients treated with ultrahypofractionated radiotherapy: a randomized controlled phase II clinical trial comparing proton versus photon radiotherapy